$19.49
0.914.90%
In chiusura: -
$19.48
-0.01000-0.05%
After hour: Oct 24, 6:54 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Tonix Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 11
Stima EPS
$-3.090
Stima dei ricavi trimestrali
$2.30M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$9.83M
Analizza lo storico degli utili di Tonix Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
TNXP | Tonix Pharmaceuticals | -$23.00 | -$3.09 | — | — | $2.82M | $2.30M | — | — | 11/11/2025 | |
TNXP | Tonix Pharmaceuticals | -$1.93K | -$2.37 | -$3.86 | -62.87% | $2.21M | $2.42M | $2.00M | -17.44% | 08/11/2025 | |
TNXP | Tonix Pharmaceuticals | -$576.00 | -$3.09 | -$2.84 | 8.09% | $2.48M | $2.60M | $2.43M | -6.58% | 05/12/2025 | |
TNXP | Tonix Pharmaceuticals | -$2.75K | -$768.00 | -$9.77 | 98.73% | $3.78M | $3.20M | $2.58M | -19.31% | 03/18/2025 | |
TNXP | Tonix Pharmaceuticals | -$3.86K | -$293.00 | -$23.00 | 92.15% | $3.99M | $3.08M | $2.82M | -8.38% | 11/12/2024 | |
TNXP | Tonix Pharmaceuticals | -$4.92K | -$720.00 | -$1.93K | -167.78% | $0.00 | $3.35M | $2.21M | -34.09% | 08/16/2024 | |
TNXP | Tonix Pharmaceuticals | -$10.40K | -$1.25K | -$576.00 | 53.85% | $0.00 | $3.80M | $2.48M | -34.68% | 05/13/2024 | |
TNXP | Tonix Pharmaceuticals | -$11.20K | -$5.25K | -$2.75K | 47.56% | $0.00 | $3.83M | $3.78M | -1.33% | 04/01/2024 | |
TNXP | Tonix Pharmaceuticals | -$13.79K | -$4.77K | -$5.86K | -22.82% | $0.00 | $5.80M | $3.99M | -31.22% | 11/09/2023 | |
TNXP | Tonix Pharmaceuticals | -$24.42K | -$8.80K | -$8.58K | 2.55% | $0.00 | — | $0.00 | — | 08/10/2023 | |
TNXP | Tonix Pharmaceuticals | -$32.00K | — | -$10.40K | — | $0.00 | — | $0.00 | — | 05/08/2023 | |
TNXP | Tonix Pharmaceuticals | -$44.80K | -$17.22K | -$11.20K | 34.94% | $0.00 | — | $0.00 | — | 03/13/2023 | |
TNXP | Tonix Pharmaceuticals | -$32.00K | -$20.42K | -$13.79K | 32.45% | $0.00 | — | $0.00 | — | 11/07/2022 | |
TNXP | Tonix Pharmaceuticals | -$44.80K | -$29.79K | -$24.42K | 18.05% | $0.00 | — | $0.00 | — | 08/08/2022 | |
TNXP | Tonix Pharmaceuticals | -$44.80K | -$32.00K | -$32.00K | 0.00% | $0.00 | — | $0.00 | — | 05/09/2022 | |
TNXP | Tonix Pharmaceuticals | -$64.00K | -$38.40K | -$44.80K | -16.67% | $0.00 | — | $0.00 | — | 03/14/2022 | |
TNXP | Tonix Pharmaceuticals | -$57.60K | -$44.80K | -$32.00K | 28.57% | $0.00 | — | $0.00 | — | 11/08/2021 | |
TNXP | Tonix Pharmaceuticals | -$147.20K | -$38.40K | -$44.80K | -16.67% | $0.00 | — | $0.00 | — | 08/09/2021 | |
TNXP | Tonix Pharmaceuticals | -$236.80K | -$32.00K | -$44.80K | -40.00% | $0.00 | — | $0.00 | — | 05/10/2021 | |
TNXP | Tonix Pharmaceuticals | -$1.83M | — | -$64.00K | — | $0.00 | — | $0.00 | — | 03/15/2021 | |
TNXP | Tonix Pharmaceuticals | -$3.64M | — | -$57.60K | — | $0.00 | — | $0.00 | — | 11/09/2020 |
Tonix Pharmaceuticals (TNXP) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-11 | $-3.86 | $-2.37 | -62.9 % |
| Q1 | 2025-05-12 | $-2.84 | $-3.09 | 8.09 % |
| Q4 | 2025-03-18 | $-9.77 | $-768.00 | 98.7 % |
| Q3 | 2024-11-12 | $-23.00 | $-293.00 | 92.2 % |
Tonix Pharmaceuticals (TNXP) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-11 | $2.00M | $2.42M | -17.4 % |
| Q1 | 2025-05-12 | $2.43M | $2.60M | -6.58 % |
| Q4 | 2025-03-18 | $2.58M | $3.20M | -19.3 % |
| Q3 | 2024-11-12 | $2.82M | $3.08M | -8.38 % |
FAQ
Quando Tonix Pharmaceuticals (NASDAQ:TNXP) riporterà gli utili?
Si prevede che Tonix Pharmaceuticals (TNXP) fornisca risultati il novembre 11, 2025. Gli ultimi risultati sono stati pubblicati il agosto 11, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Tonix Pharmaceuticals (NASDAQ:TNXP)?
L'EPS effettivo era $-3.86, che mancato la stima di $-2.37.
Quali sono state le entrate di Tonix Pharmaceuticals (NASDAQ:TNXP)?
Le entrate effettive sono state $2M, che mancato la stima di $2.4M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.